Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping

The world’s biggest maker of generic drugs has been squeezed by increased competition and lower prices and is saddled with a large amount of debt.

from NYT > Health http://ift.tt/2AZwdj7
via health&fitness